losartan has been researched along with Syndrome in 6 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
Syndrome: A characteristic symptom complex.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Kounis syndrome is hypersensitivity coronary disorder induced by various types of environmental exposures, drugs, conditions and stents." | 2.52 | Foods, Drugs and Environmental Factors: Novel Kounis Syndrome Offenders. ( Giannopoulos, S; Goudevenos, J; Kounis, GN; Kounis, NG; Soufras, GD, 2015) |
| "Losartan is known to inhibit transforming growth factor β signaling and may be a specific modulator of disease expression in this syndrome." | 1.37 | Arterial tortuosity syndrome with multiple intracranial aneurysms: a case report. ( Levinson, JR; MacRae, CA; Nahed, BV; Naunheim, MR; Ogilvy, CS; Walcott, BP, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Aung, TKK | 1 |
| Chuah, TY | 1 |
| Chua, MWJ | 1 |
| Kounis, NG | 1 |
| Giannopoulos, S | 1 |
| Soufras, GD | 1 |
| Kounis, GN | 1 |
| Goudevenos, J | 1 |
| Dai, Q | 1 |
| Zhang, PQ | 1 |
| Wang, XQ | 1 |
| Nie, LF | 1 |
| Fu, XJ | 1 |
| Peng, W | 1 |
| Wang, Y | 1 |
| Li, J | 1 |
| Bi, YP | 1 |
| Mi, XH | 1 |
| Yuan, M | 1 |
| He, LQ | 1 |
| Naunheim, MR | 1 |
| Walcott, BP | 1 |
| Nahed, BV | 1 |
| MacRae, CA | 1 |
| Levinson, JR | 1 |
| Ogilvy, CS | 1 |
| Stewart, JM | 1 |
| Taneja, I | 1 |
| Glover, J | 1 |
| Medow, MS | 1 |
| Pecci, A | 1 |
| Granata, A | 1 |
| Fiore, CE | 1 |
| Balduini, CL | 1 |
1 review available for losartan and Syndrome
| Article | Year |
|---|---|
Foods, Drugs and Environmental Factors: Novel Kounis Syndrome Offenders.
Topics: Actinidia; Adrenal Cortex Hormones; Anaphylaxis; Antihypertensive Agents; Contrast Media; Coronary V | 2015 |
2 trials available for losartan and Syndrome
| Article | Year |
|---|---|
[Treatment of Proteinuria in Chronic Glomerular Disease Patients with Pi-Shen Deficiency Complicated Damp-Heat Syndrome by Yishen Qingre Huashi Recipe: a Clinical Study].
Topics: Blood Urea Nitrogen; Drugs, Chinese Herbal; Hot Temperature; Humans; Kidney Diseases; Kidney Glomeru | 2015 |
Angiotensin II type 1 receptor blockade corrects cutaneous nitric oxide deficit in postural tachycardia syndrome.
Topics: Administration, Cutaneous; Adolescent; Adult; Angiotensin II Type 1 Receptor Blockers; Blood Flow Ve | 2008 |
3 other studies available for losartan and Syndrome
| Article | Year |
|---|---|
More Than Meets the Eye: A Patient with Hand Swelling and Newly Diagnosed Diabetes Mellitus.
Topics: Aged; Amlodipine; Anemia; Antihypertensive Agents; Blood Sedimentation; C-Reactive Protein; Diabetes | 2021 |
Arterial tortuosity syndrome with multiple intracranial aneurysms: a case report.
Topics: Aged; Angiography; Antihypertensive Agents; Aorta; Aspirin; Circle of Willis; Connective Tissue Dise | 2011 |
Renin-angiotensin system blockade is effective in reducing proteinuria of patients with progressive nephropathy caused by MYH9 mutations (Fechtner-Epstein syndrome).
Topics: Adolescent; Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors | 2008 |